Notices - 2011
[Federal Register Volume 76, Number 118 (Monday, June 20, 2011)]
[Notices]
[Pages 35913-35914]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-15130]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0010]
Agency Information Collection Activities: Proposed Collection;
Comments Requested: U.S. Official Order Forms for Schedule I and II
Controlled Substances (Accountable Forms); Order Form Requisition; DEA
Form 222, 222a, Controlled Substances Order System
ACTION: 30-Day notice of information collection under review.
The Department of Justice (DOJ), Drug Enforcement Administration
(DEA) will be submitting the following information collection request
to the Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. The proposed
information collection is published to obtain comments from the public
and affected agencies. This proposed information collection was
previously published in the Federal Register at Volume 76, Number 71,
Page 20710, April 13, 2011, allowing for a 60-day comment period.
The purpose of this notice is to allow for an additional 30 days
for public comment until July 20, 2011. This process is conducted in
accordance with 5 CFR 1320.10.
If you have comments, especially on the estimated public burden or
associated response time, suggestions, or need a copy of the proposed
information collection instrument with instructions or additional
information, please contact Cathy A. Gallagher, Acting Chief, Liaison
and Policy Section, Office of Diversion Control, Drug Enforcement
Administration, 8701 Morrissette Drive, Springfield, VA 22152; (202)
307-7297.
Written comments concerning this information collection should be
sent to the Office of Information and Regulatory Affairs, Office of
Management and Budget, Attn: DOJ Desk Officer. The best way to ensure
your comments are received is to e-mail them to oira_submission@omb.eop.gov or fax them to (202) 395-7285. All comments
should reference the eight-digit OMB number for the collection or the
title of the collection. If you have questions concerning the
collection, please contact Cathy A. Gallagher, Acting Chief, Liaison
and Policy Section, Office of Diversion Control, Drug Enforcement
Administration, 8701 Morrissette Drive, Springfield, VA 22152, (202)
307-7297, or the DOJ Desk Officer at (202) 395-3176.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
Evaluate the accuracy of the agencies estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used;
Enhance the quality, utility, and clarity of the
information to be collected; and
Minimize the burden of the collection of information on
those who are to respond, including through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses.
Overview of Information Collection 1117-0010
(1) Type of Information Collection: Extension of a currently
approved collection.
(2) Title of the Form/Collection: U.S. Official Order Forms for
Schedule I and II Controlled Substances (Accountable Forms); Order Form
Requisition.
(3) Agency form number, if any, and the applicable component of the
Department sponsoring the collection:
Form number: DEA Forms 222 and 222a.
Component: Office of Diversion Control, Drug Enforcement
Administration, Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: Business or other for-profit.
Other: Not-for-profit; State, local or Tribal government.
Abstract: DEA-222 is used to transfer or purchase Schedule I and II
controlled substances and data are needed to provide an audit of
transfer and purchase. DEA-222a Requisition Form is used to obtain the
DEA-222 Order Form. Persons may also digitally sign and transmit orders
for controlled substances electronically, using a digital certificate.
Orders for Schedule I and II controlled substances are archived and
transmitted to DEA.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: DEA estimates
that 109,632
[[Page 35914]]
registrants participate in this information collection, taking an
estimated 17.33 hours per registrant annually.
(6) An estimate of the total public burden (in hours) associated
with the collection: It is estimated that there are 1,898,970 annual
burden hours associated with this collection.
If additional information is required contact: Jerri Murray,
Department Clearance Officer, Policy and Planning Staff, Justice
Management Division, Department of Justice, Two Constitution Square,
145 N Street, NE., Suite 2E-808, Washington, DC 20530.
Jerri Murray,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. 2011-15130 Filed 6-17-11; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).
|
